Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis A pediatric vaccine
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Hepatitis A pediatric vaccine is an inactivated virus vaccine used for active immunization against disease caused by hepatitis A virus (HAV) in children. The vaccine works by exposing the child to a small amount of the virus, which causes the body to develop immunity to the disease. It helps prevent hepatitis A, a serious disease that causes inflammation of the liver, vomiting, and jaundice, and can lead to liver cancer, cirrhosis, or death.
- Brand names
- Havrix PediatricVaqta Pediatric
Beyond the preview
Go deeper on hepatitis A pediatric vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis A pediatric vaccine.